These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 23047694)

  • 1. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.
    Bernardo BC; Gao XM; Tham YK; Kiriazis H; Winbanks CE; Ooi JY; Boey EJ; Obad S; Kauppinen S; Gregorevic P; Du XJ; Lin RC; McMullen JR
    PLoS One; 2014; 9(2):e90337. PubMed ID: 24587330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
    Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
    RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.
    Bernardo BC; Nguyen SS; Winbanks CE; Gao XM; Boey EJ; Tham YK; Kiriazis H; Ooi JY; Porrello ER; Igoor S; Thomas CJ; Gregorevic P; Lin RC; Du XJ; McMullen JR
    FASEB J; 2014 Dec; 28(12):5097-110. PubMed ID: 25145628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
    Bernardo BC; Yildiz GS; Kiriazis H; Harmawan CA; Tai CMK; Ritchie RH; McMullen JR
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.
    Rottiers V; Obad S; Petri A; McGarrah R; Lindholm MW; Black JC; Sinha S; Goody RJ; Lawrence MS; deLemos AS; Hansen HF; Whittaker S; Henry S; Brookes R; Najafi-Shoushtari SH; Chung RT; Whetstine JR; Gerszten RE; Kauppinen S; Näär AM
    Sci Transl Med; 2013 Nov; 5(212):212ra162. PubMed ID: 24259050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
    Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
    Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.
    Martinez EC; Lilyanna S; Wang P; Vardy LA; Jiang X; Armugam A; Jeyaseelan K; Richards AM
    J Mol Cell Cardiol; 2017 Nov; 112():27-39. PubMed ID: 28865712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
    Hinkel R; Batkai S; Bähr A; Bozoglu T; Straub S; Borchert T; Viereck J; Howe A; Hornaschewitz N; Oberberger L; Jurisch V; Kozlik-Feldmann R; Freudenthal F; Ziegler T; Weber C; Sperandio M; Engelhardt S; Laugwitz KL; Moretti A; Klymiuk N; Thum T; Kupatt C
    J Am Coll Cardiol; 2021 Jun; 77(23):2923-2935. PubMed ID: 34112319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury.
    Hinkel R; Ramanujam D; Kaczmarek V; Howe A; Klett K; Beck C; Dueck A; Thum T; Laugwitz KL; Maegdefessel L; Weber C; Kupatt C; Engelhardt S
    J Am Coll Cardiol; 2020 Apr; 75(15):1788-1800. PubMed ID: 32299591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
    Bernardo BC; Nguyen SS; Gao XM; Tham YK; Ooi JY; Patterson NL; Kiriazis H; Su Y; Thomas CJ; Lin RC; Du XJ; McMullen JR
    Sci Rep; 2016 Mar; 6():22442. PubMed ID: 26928825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Cell Type-Specific Effects of MicroRNA-92a Provides Novel Insights Into Target Regulation and Mechanism of Action.
    Rogg EM; Abplanalp WT; Bischof C; John D; Schulz MH; Krishnan J; Fischer A; Poluzzi C; Schaefer L; Bonauer A; Zeiher AM; Dimmeler S
    Circulation; 2018 Nov; 138(22):2545-2558. PubMed ID: 30571345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LNA-mediated microRNA silencing in non-human primates.
    Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
    Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
    Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
    Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of miR-15 protects against cardiac ischemic injury.
    Hullinger TG; Montgomery RL; Seto AG; Dickinson BA; Semus HM; Lynch JM; Dalby CM; Robinson K; Stack C; Latimer PA; Hare JM; Olson EN; van Rooij E
    Circ Res; 2012 Jan; 110(1):71-81. PubMed ID: 22052914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.
    Patrick DM; Montgomery RL; Qi X; Obad S; Kauppinen S; Hill JA; van Rooij E; Olson EN
    J Clin Invest; 2010 Nov; 120(11):3912-6. PubMed ID: 20978354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models.
    Pan Z; Sun X; Ren J; Li X; Gao X; Lu C; Zhang Y; Sun H; Wang Y; Wang H; Wang J; Xie L; Lu Y; Yang B
    PLoS One; 2012; 7(11):e50515. PubMed ID: 23226300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity.
    Naseri Z; Oskuee RK; Forouzandeh-Moghadam M; Jaafari MR
    Stem Cell Rev Rep; 2020 Jun; 16(3):541-556. PubMed ID: 31898802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
    Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.